Diagnostic Microbiology & Infectious Disease
Volume 67, Issue 3 , Pages 270-276 , July 2010

AmpC β-lactamases in Escherichia coli: emergence of CMY-2–producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b–ST131

  • Jesús Oteo

      Affiliations

    • Antibiotic Laboratory, Bacteriology Service, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain
    • Corresponding Author InformationCorresponding author. Centro Nacional de Microbiología, Instituto de Salud Carlos III, Carretera Pozuelo a Majadahonda, 28220 Majadahonda, Madrid, Spain. Tel.: +34-918223650; fax: +34-915097966.
    • ,
  • Emilia Cercenado

      Affiliations

    • Microbiology Department, Hospital Gregorio Marañón, 28007 Madrid, Spain
    • ,
  • Óscar Cuevas

      Affiliations

    • Antibiotic Laboratory, Bacteriology Service, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain
    • ,
  • Verónica Bautista

      Affiliations

    • Antibiotic Laboratory, Bacteriology Service, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain
    • ,
  • Alberto Delgado-Iribarren

      Affiliations

    • Microbiology Department, Hospital Fundación de Alcorcón, Alcorcón, 28922 Madrid, Spain
    • ,
  • Beatriz Orden

      Affiliations

    • Microbiology Department, Centro de Especialidades Argüelles, Hospital Puerta de Hierro, 28760 Madrid, Spain
    • ,
  • María Pérez-Vázquez

      Affiliations

    • Antibiotic Laboratory, Bacteriology Service, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain
    • ,
  • Silvia García-Cobos

      Affiliations

    • Antibiotic Laboratory, Bacteriology Service, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain
    • ,
  • José Campos

      Affiliations

    • Antibiotic Laboratory, Bacteriology Service, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain
    • Consejo Superior de Investigaciones Científicas, 28006 Madrid, Spain

Received 20 November 2009 ,Accepted 12 February 2010.

References 

  1. Baudry PJ, Mataseje L, Zhanel GG, Hoban DJ, Mulvey MR. Characterization of plasmids encoding CMY-2 AmpC beta-lactamases from Escherichia coli in Canadian intensive care units. Diagn. Microbiol. Infect. Dis. 2009;65:379–383
  2. Caroff N, Espaze E, Gautreau D, Richet H, Reynaud A. Analysis of the effects of −42 and −32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC. J. Antimicrob. Chemother. 2000;45:783–788
  3. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 2000;66:4555–4558
  4. Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, Branger C, et al. The CTX-M-15–producing Escherichia coli diffusing clone belongs to a highly virulent phylogenetic subgroup. J. Antimicrob. Chemother. 2008;61:1024–1028
  5. Clinical and Laboratory Standards Institute (CLSI) . Performance standards for antimicrobial susceptibility testing: 17th informational supplement (M100-S17), vol. 27, no. 1. Wayne, PA: CLSI; 2007;
  6. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 2008;14:195–200
  7. Corvec S, Prodhomme A, Giraudeau C, Dauvergne S, Reynaud A, Caroff N. Most Escherichia coli strains overproducing chromosomal AmpC beta-lactamase belong to phylogenetic group A. J. Antimicrob. Chemother. 2007;60:872–876
  8. European Antimicrobial Resistance Surveillance System . Available at: http://www.rivm.nl/earss/2010;Accessed January 15, 2010
  9. Farmer JJ, Boatwright KD, Michael J. Enterobacteriaceae: introduction and identification. In:  Murray PR,  Baron EJ,  Jorgersen JH,  Landry ML,  Pfaller MA editor. Manual of clinical microbiology. Washington: ASM Press; 2007;p. 649–669
  10. Haldorsen B, Aasnaes B, Dahl KH, Hanssen AM, Simonsen GS, Walsh TR, et al. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC. J. Antimicrob. Chemother. 2008;62:694–702
  11. Hanson ND, Moland ES, Hong SG, Propst K, Novak DJ, Cavalieri SJ. Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 β-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community. Antimicrob. Agents Chemother. 2008;52:3814–3816
  12. Li Y, Li Q, Du Y, Jiang X, Tang J, Wang J, et al. Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2–type AmpC beta-lactamase resistance in China. J. Clin. Microbiol. 2008;46:1317–1321
  13. Mammeri H, Eb F, Berkani A, Nordman P. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital. J. Antimicrob. Chemother. 2008;61:498–503
  14. Mata C, Miró E, Rivera A, Mirelis B, Coll P, Navarro F. Prevalence of acquired AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007. Clin. Microbiol. Infect. PMID. 2009;19523051:
  15. Mataseje LF, Neumann N, Crago B, Baudry P, Zhanel GG, Louie M, et al. Characterization of cefoxitin-resistant Escherichia coli isolates from recreational beaches and private drinking water in Canada between 2004 and 2006. Antimicrob. Agents. Chemother. 2009;53:3126–3130
  16. Moreno E, Prats G, Sabaté M, Pérez T, Johnson JR, Andreu A. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J. Antimicrob. Chemother. 2006;57:204–211
  17. Naseer U, Haldorsen B, Simonsen GS, Sundsfjord A. Sporadic occurrence of CMY-2–producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway. Clin. Microbiol. Infect. 2009;16:171–178
  18. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Caniça MM, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 2008;61:273–281
  19. Oteo J, Lázaro E, de Abajo FJ, Baquero F, Campos J and Spanish members of EARSS. Antimicrobial-resistant invasive Escherichia coli. Spain Emerg. Infect. Dis. 2005;11:546–553
  20. Oteo J, Navarro C, Cercenado E, Delgado-Irribarren A, Wilhelmi I, Orden B, et al. High-level of cefotaxime and ceftazidime resistance in Escherichia coli: spread of clonal and unrelated isolates between the community, long-term care facilities and hospital institutions. J. Clin. Microbiol. 2006;44:2359–2366
  21. Oteo J, Diestra K, Juan C, Bautista V, Novais A, Pérez-Vázquez M, et al. Extended-spectrum beta-lactamase–producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2. Int. J. Antimicrob. Agents. 2009;34:173–176
  22. Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 2002;40:2153–2162
  23. Pitout JD, Gregson DB, Church DL, Laupland KB. Population-based laboratory surveillance for AmpC β-lactamase–producing Escherichia coli, Calgary. Emerg. Infect. Dis. 2007;13:443–448
  24. Potz N, Hope R, Warmer M, Johnson AP, Livermore DM London & South East ESBL Project Group. Prevalence and mechanisms of cephalosporins resistance in Enterobacteriaceae in London and South-East England. J. Antimicrob. Chemother. 2006;58:320–326
  25. Roche C, Boo TW, Walsh F, Crowley B. Detection and molecular characterisation of plasmidic AmpC beta-lactamases in Klebsiella pneumoniae isolates from a tertiary-care hospital in Dublin, Ireland. Clin. Microbiol. Infect. 2008;14:616–618
  26. Sidjabat HE, Paterson DL, Qureshi ZA, Adams-Haduch , O'Keefe A, Pascual A, et al. Clinical features and molecular epidemiology of CMY-type β-lactamase–producing Escherichia coli. Clin. Infect. Dis. 2009;48:739–744
  27. Suzuki S, Shibata N, Yamane K, Wachino J, Ito K, Arakawa Y. Change in the prevalence of extended-spectrum-β-lactamase–producing Escherichia coli in Japan by clonal spread. J. Antimicrob. Chemother. 2009;63:72–79
  28. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis criteria for bacterial strain typing. J. Clin. Microbiol. 1995;33:2233–2239
  29. Woodford N, Reddy S, Fagan EJ, Hill RL, Hopkins KL, Kaufmann ME, et al. Wide geographic spread of diverse acquired AmpC-type β-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland. J. Antimicrob. Chemother. 2007;59:102–105

PII: S0732-8893(10)00044-1

doi: 10.1016/j.diagmicrobio.2010.02.008

Diagnostic Microbiology & Infectious Disease
Volume 67, Issue 3 , Pages 270-276 , July 2010

Article Tools

* Image Usage & Resolution